<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Advances in Molecular Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Advances in Molecular Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Успехи молекулярной онкологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-805X</issn><issn publication-format="electronic">2413-3787</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">413</article-id><article-id pub-id-type="doi">10.17650/2313-805X-2022-9-1-20-32</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Expression of miR-302a, miR-302b, miR-302c, miR-302d, miR-367, miR-371, miR-372, miR-373, miR-10b, miR-21 and miR-93 in cells of different histotypes of testicular germ cell tumors</article-title><trans-title-group xml:lang="ru"><trans-title>Уровень экспрессии miR-302a, miR-302b, miR-302c, miR-302d, miR-367, miR-371, miR-372, miR-373, miR-10b, miR-21 и miR-93 клетками различных гистотипов герминогенных опухолей яичка</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Knyazeva</surname><given-names>M. S.</given-names></name><name xml:lang="ru"><surname>Князева</surname><given-names>М. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesochny Settlment, Saint Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zagoruiko</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Загоруйко</surname><given-names>В. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesochny Settlment, Saint Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khokhlova</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Хохлова</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesochny Settlment, Saint Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nazarova</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Назарова</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesochny Settlment, Saint Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shalaev</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Шалаев</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesochny Settlment, Saint Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sidina</surname><given-names>E. I.</given-names></name><name xml:lang="ru"><surname>Сидина</surname><given-names>Е. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesochny Settlment, Saint Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zabegina</surname><given-names>L. M.</given-names></name><name xml:lang="ru"><surname>Забегина</surname><given-names>Л. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesochny Settlment, Saint Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Artemyeva</surname><given-names>A. S.</given-names></name><name xml:lang="ru"><surname>Артемьева</surname><given-names>А. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesochny Settlment, Saint Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nosov</surname><given-names>A. K.</given-names></name><name xml:lang="ru"><surname>Носов</surname><given-names>А. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesochny Settlment, Saint Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Protsenko</surname><given-names>S. A.</given-names></name><name xml:lang="ru"><surname>Проценко</surname><given-names>С. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>68 Leningradskaya St., Pesochny Settlment, Saint Petersburg 197758</p></bio><bio xml:lang="ru"><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Malek</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Малек</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><bold>Anastasia Valeryevna Malek </bold></p><p>68 Leningradskaya St., Pesochny Settlment, Saint Petersburg 197758</p></bio><bio xml:lang="ru"><p><bold>Анастасия Валерьевна Малек</bold>  </p><p>197758 Санкт-Петербург, пос. Песочный, ул. Ленинградская, 68</p></bio><email>anastasia@malek.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Петрова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2022</year></pub-date><volume>9</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>20</fpage><lpage>32</lpage><history><date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Knyazeva M.S., Zagoruiko V.A., Khokhlova A.V., Nazarova I.V., Shalaev A.V., Sidina E.I., Zabegina L.M., Artemyeva A.S., Nosov A.K., Protsenko S.A., Malek A.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Князева М.С., Загоруйко В.А., Хохлова А.В., Назарова И.В., Шалаев А.В., Сидина Е.И., Забегина Л.М., Артемьева А.С., Носов А.К., Проценко С.А., Малек А.В.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Knyazeva M.S., Zagoruiko V.A., Khokhlova A.V., Nazarova I.V., Shalaev A.V., Sidina E.I., Zabegina L.M., Artemyeva A.S., Nosov A.K., Protsenko S.A., Malek A.V.</copyright-holder><copyright-holder xml:lang="ru">Князева М.С., Загоруйко В.А., Хохлова А.В., Назарова И.В., Шалаев А.В., Сидина Е.И., Забегина Л.М., Артемьева А.С., Носов А.К., Проценко С.А., Малек А.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://umo.abvpress.ru/jour/article/view/413">https://umo.abvpress.ru/jour/article/view/413</self-uri><abstract xml:lang="en"><p><bold>Introduction.</bold> Testicular germ cell tumor is a relatively rare disease. Its high social significance is due to the fact that this pathology occurs in young patients. The standard schemes of polychemotherapy determine the potential possibility of effective treatment for most of the patients even with an advanced disease. Several circulating markers (alpha-fetoprotein, human chorionic gonadotropin and lactate dehydrogenase) are being used for therapy monitoring, but the low diagnostic specificity of these molecules determines the need to develop new approaches. Over the past years, circulating microRNA, for instance miR-371a-3p, appeared to be promising marker for testicular germ cell tumor monitoring. However, to develop and to implement in practice the microRNA-based diagnostic technologies, it’s necessarily to understand the features of the microRNA expression alterations specific for different histological types of testicular germ cell tumor.<bold>The study objective</bold> – to evaluate changes in the expression of several potential marker microRNA molecules (miR-302/ miR-367, miR-371/miR-373) in testicular germ cell tumor samples of various histological types.<bold>Materials and methods.</bold> Testicular germ cell tumor samples (n = 61), including seminomas, embryonic carcinomas, post-pubertal teratomas, yolk sac tumors, chorioncarcinomas, and corresponding normal tissue samples (n = 61) were included in the study. The analysis of selected miRNA expression was performed by reverse transcription and polymerase chain reaction.<bold>Results.</bold> We identified the changes in the expression profile of the miR-302/miR-367 cluster typical for semines, embryonic carcinomas, post-pubertal teratomas, yolk sac tumors and chorioncarcinomas, as well as changes in the expression profile of the miR-371/miR-373 cluster, universal for all histotypes except chorioncarcinomas. Inhibition of miR-10b and miR-145 expression in semines, embryonic carcinomas, and post-pubertal teratomas was demonstrated.<bold>Conclusion.</bold> Activation of miR-302b, miR-302d, miR-371a expression and inhibition of miR-10b, miR-145 expression in the tissue of the most common variants of testicular germ cell tumor is a characteristic feature of these tumors. The detected changes are significant and can lead to corresponding changes in the profile of circulating microRNAs.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение.</bold> Герминогенные опухоли яичка являются относительно редким заболеванием. высокая социальная значимость данной патологии обусловлена тем, что она встречается у больных молодого возраста. современные схемы полихимиотерапии определяют потенциальную возможность излечения большинства пациентов даже при распространенном опухолевом процессе. Эффективность терапии оценивается путем мониторинга ряда маркеров (альфафетопротеина, хорионического гонадотропина человека и лактатдегидрогеназы), но низкая диагностическая специфичность этих молекул обусловливает необходимость разработки новых методов. В течение последних лет проводятся исследования возможности использования в качестве маркера герминогенных опухолей яичка циркулирующих микрорнк. Для создания и внедрения в практику технологий их анализа необходимо понять особенности экспрессионных изменений потенциально маркерных молекул в клетках различных гистологических вариантов герминогенных новообразований яичка.<bold>Цель исследования</bold> – проанализировать экспрессию молекул микроРНК (miR-302/miR-367, miR-371/miR-373) в образцах герминогенных опухолей яичка различных гистологических типов.<bold>Материалы и методы</bold>. В исследование были включены образцы герминогенных опухолей яичка (n = 61), в том числе семином, эмбриональных карцином, тератом постпубертатного типа, опухолей желточного мешка, хорионкарцином, и образцы нормальной ткани (n = 61). Анализ проведен с помощью методов обратной транскрипции и полимеразной цепной реакции.<bold>Результаты.</bold> Описаны изменения экспрессии молекул кластера miR-302/miR-367, характерные для семином, эмбриональных карцином и опухолей желчеточного мешочка, а также изменения экспрессии кластера miR-371/miR-373, универсальные для всех гистотипов, кроме хорионкарцином. Показано угнетение экспрессионной активности miR- 10b и miR-145 в семиномах, эмбриональных карциномах и тератомах постпубертатного типа.<bold>Заключение.</bold> Повышение уровней экспрессии miR-302b, miR-302d, miR-371a и снижение уровней экспрессии miR- 10b, miR-145 характерны для наиболее часто встречающихся вариантов герминогенных опухолей яичка. Обнаруженные изменения существенны и могут привести к изменениям профиля циркулирующих микрорнк.</p></trans-abstract><kwd-group xml:lang="en"><kwd>microRNA</kwd><kwd>testicular germ cell tumors</kwd><kwd>reverse transcription</kwd><kwd>polymerase chain reaction</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>микроРНК</kwd><kwd>герминогенные опухоли яичка</kwd><kwd>обратная транскрипция</kwd><kwd>полимеразная цепная реакция</kwd></kwd-group><funding-group><funding-statement xml:lang="en">The study was funded in the frame of state assignment to N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia to project “Development and clinical testing of methods for diagnostics and prediction of the cancer therapy effect on the base microRNA analysis in biopsy material”.</funding-statement><funding-statement xml:lang="ru">Исследование финансировалось из бюджета государственного задания ФГБУ «Национальный медицинский центр онкологии им. Н.Н. Петрова» Минздрава России по теме «Разработка и клиническая апробация методов диагностики и прогнозирования эффекта терапии онкологических заболеваний на основе анализа микроРНК в биопсийном материале».</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Regouc M., Belge G., Lorch A. et al. Non-coding microRNAs as novel potential tumor markers in testicular cancer. Cancers (Basel) 2020;12(3):749. DOI: 10.3390/cancers12030749. Available at: https://www.mdpi.com/2072-6694/12/3/749.</mixed-citation><mixed-citation xml:lang="ru">Regouc M., Belge G., Lorch A. et al. Non-coding microRNAs as novel potential tumor markers in testicular cancer. Cancers (Basel) 2020;12(3):749. DOI: 10.3390/cancers12030749. Available at: https://www.mdpi.com/2072-6694/12/3/749.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Dieckmann K.-P., Spiekermann M., Balks T. et al. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 2012;107(10):1754–60. DOI: 10.1038/bjc.2012.469.</mixed-citation><mixed-citation xml:lang="ru">Dieckmann K.-P., Spiekermann M., Balks T. et al. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 2012;107(10):1754–60. DOI: 10.1038/bjc.2012.469.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Носов А.К., Мамижев Э.М., Рева С.А. и др. Влияние задержки диагностики на догоспитальном этапе на результаты лечения больных с герминогенными опухолями яичка в Санкт-Петербурге. Онкоурология 2013;2:63–8. [Nosov A.K., Mamizhev E.M., Reva S.A. et al. The effect of delayed diagnosis at the prehospital stage on the results of treatment of patients with germinogenic testicular tumors in Saint-Petersburg. Onkourologiya = Oncourology 2013;2:63–8. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Носов А.К., Мамижев Э.М., Рева С.А. и др. Влияние задержки диагностики на догоспитальном этапе на результаты лечения больных с герминогенными опухолями яичка в Санкт-Петербурге. Онкоурология 2013;2:63–8. [Nosov A.K., Mamizhev E.M., Reva S.A. et al. The effect of delayed diagnosis at the prehospital stage on the results of treatment of patients with germinogenic testicular tumors in Saint-Petersburg. Onkourologiya = Oncourology 2013;2:63–8. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Skakkebæk N. Possible carcinoma-in-situ of the testis. Lancet 1972;2(7776):516–7. DOI: 10.1016/s0140-6736(72)91909-5.</mixed-citation><mixed-citation xml:lang="ru">Skakkebæk N. Possible carcinoma-in-situ of the testis. Lancet 1972;2(7776):516–7. DOI: 10.1016/s0140-6736(72)91909-5.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Batool A., Karimi N., Wu X.-N. et al. Testicular germ cell tumor: a comprehensive review. Cell Mol Life Sci 2019;76(9):1713–27. DOI: 10.1007/s00018-019-03022-7.</mixed-citation><mixed-citation xml:lang="ru">Batool A., Karimi N., Wu X.-N. et al. Testicular germ cell tumor: a comprehensive review. Cell Mol Life Sci 2019;76(9):1713–27. DOI: 10.1007/s00018-019-03022-7.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Трякин А.А., Гладков О.А., Матвеев В.Б. и др. Практические рекомендации по лечению герминогенных опухолей у мужчин. 2020. Злокачественные опухоли. Практические рекомендации RUSSCO #3s2 2020;10:34. [Tryakin A.A., Gladkov O.A., Matveev V.B. et al. Practical recommendations for the treatment of germinogenic tumors in men. 2020. Zlokachestvennye opuholi. Prakticheskie rekomendacii = Malignant tumors. Practical recommendations of RUSSCO #3s2 2020;10:34. (In Russ.)]. DOI: 10.18027/2224-5057-2020-10-3s2-34.</mixed-citation><mixed-citation xml:lang="ru">Трякин А.А., Гладков О.А., Матвеев В.Б. и др. Практические рекомендации по лечению герминогенных опухолей у мужчин. 2020. Злокачественные опухоли. Практические рекомендации RUSSCO #3s2 2020;10:34. [Tryakin A.A., Gladkov O.A., Matveev V.B. et al. Practical recommendations for the treatment of germinogenic tumors in men. 2020. Zlokachestvennye opuholi. Prakticheskie rekomendacii = Malignant tumors. Practical recommendations of RUSSCO #3s2 2020;10:34. (In Russ.)]. DOI: 10.18027/2224-5057-2020-10-3s2-34.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Honecker F., Aparicio J., Berney D. et al. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol 2018;29(8):1658–86. DOI: 10.1093/annonc/mdy217.</mixed-citation><mixed-citation xml:lang="ru">Honecker F., Aparicio J., Berney D. et al. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol 2018;29(8):1658–86. DOI: 10.1093/annonc/mdy217.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Svetlovska D., Miskovska V., Cholujova D. et al. Plasma cytokines correlated with disease characteristics, progressionfree survival, and overall survival in testicular germ-cell tumor patients. Clin Genitourin Cancer 2017;15(3):411–6.e2. DOI: 10.1016/j.clgc.2017.01.027.</mixed-citation><mixed-citation xml:lang="ru">Svetlovska D., Miskovska V., Cholujova D. et al. Plasma cytokines correlated with disease characteristics, progressionfree survival, and overall survival in testicular germ-cell tumor patients. Clin Genitourin Cancer 2017;15(3):411–6.e2. DOI: 10.1016/j.clgc.2017.01.027.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Zhang T., Ji L., Liu B. et al. Testicular germ cell tumors: a clinicopathological and immunohistochemical analysis of 145 cases. Int J Clin Exp Pathol 2018;11(9):4622–9.</mixed-citation><mixed-citation xml:lang="ru">Zhang T., Ji L., Liu B. et al. Testicular germ cell tumors: a clinicopathological and immunohistochemical analysis of 145 cases. Int J Clin Exp Pathol 2018;11(9):4622–9.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Chieffi P. An up-date on novel molecular targets in testicular germ cell tumors subtypes. Intractable Rare Dis Res 2019;8(2):161–4. DOI: 10.5582/irdr.2019.01055.</mixed-citation><mixed-citation xml:lang="ru">Chieffi P. An up-date on novel molecular targets in testicular germ cell tumors subtypes. Intractable Rare Dis Res 2019;8(2):161–4. DOI: 10.5582/irdr.2019.01055.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Leão R., Ahmad A.E., Hamilton R.J. Testicular cancer biomarkers: A Role for precision medicine in testicular cancer. Clin Genitourin Cancer 2019;17(1):e176–83.</mixed-citation><mixed-citation xml:lang="ru">Leão R., Ahmad A.E., Hamilton R.J. Testicular cancer biomarkers: A Role for precision medicine in testicular cancer. Clin Genitourin Cancer 2019;17(1):e176–83.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Murray M.J., Saini H.K., van Dongen S. et al. The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression. Mol Cancer 2010;9:290. DOI: 10.1186/1476-4598-9-290.</mixed-citation><mixed-citation xml:lang="ru">Murray M.J., Saini H.K., van Dongen S. et al. The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression. Mol Cancer 2010;9:290. DOI: 10.1186/1476-4598-9-290.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Das M.K., Evensen H.S.F., Furu K., Haugen T.B. miRNA-302s may act as oncogenes in human testicular germ cell tumours. Sci Rep 2019;9:9189. DOI: 10.1038/s41598-019-45573-6.</mixed-citation><mixed-citation xml:lang="ru">Das M.K., Evensen H.S.F., Furu K., Haugen T.B. miRNA-302s may act as oncogenes in human testicular germ cell tumours. Sci Rep 2019;9:9189. DOI: 10.1038/s41598-019-45573-6.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Batool A., Liu X.-M., Zhang C.-L. et al. Recent advances in the regulation of testicular germ cell tumors by microRNAs. Front Biosci 2019;24:4749. DOI: 10.2741/4749.</mixed-citation><mixed-citation xml:lang="ru">Batool A., Liu X.-M., Zhang C.-L. et al. Recent advances in the regulation of testicular germ cell tumors by microRNAs. Front Biosci 2019;24:4749. DOI: 10.2741/4749.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Andersen C.L., Jensen J.L., Ørntoft T.F. Normalization of real-time quantitative reverse transcription-PCR data: a modelbased variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004;64(15):5245–50. DOI: 10.1158/0008-5472.CAN-04-0496.</mixed-citation><mixed-citation xml:lang="ru">Andersen C.L., Jensen J.L., Ørntoft T.F. Normalization of real-time quantitative reverse transcription-PCR data: a modelbased variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004;64(15):5245–50. DOI: 10.1158/0008-5472.CAN-04-0496.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data Using realtime quantitative PCR and the 2(Delta DElta C(T)) method. Methods 2001;25(4):402–8. DOI: 10.1006/meth.2001.1262.</mixed-citation><mixed-citation xml:lang="ru">Livak K.J., Schmittgen T.D. Analysis of relative gene expression data Using realtime quantitative PCR and the 2(Delta DElta C(T)) method. Methods 2001;25(4):402–8. DOI: 10.1006/meth.2001.1262.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Kruskal W.H., Wallis W.A. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952;47(260):583. Available at: https://www.jstor.org/stable/2280779?origin=crossref.</mixed-citation><mixed-citation xml:lang="ru">Kruskal W.H., Wallis W.A. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952;47(260):583. Available at: https://www.jstor.org/stable/2280779?origin=crossref.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Mann H.B., Whitney D.R. On a test of whether one of two random Variables is stochastically larger than the other. Ann Math Stat 1947;18(1):50–60. DOI: 10.1214/aoms/1177730491.</mixed-citation><mixed-citation xml:lang="ru">Mann H.B., Whitney D.R. On a test of whether one of two random Variables is stochastically larger than the other. Ann Math Stat 1947;18(1):50–60. DOI: 10.1214/aoms/1177730491.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Guo M., Gan L., Si J. et al. Role of miR-302/367 cluster in human physiology and pathophysiology. Acta Biochim Biophys Sin (Shanghai) 2020;52(8):791–800. DOI: 10.1093/abbs/gmaa065.</mixed-citation><mixed-citation xml:lang="ru">Guo M., Gan L., Si J. et al. Role of miR-302/367 cluster in human physiology and pathophysiology. Acta Biochim Biophys Sin (Shanghai) 2020;52(8):791–800. DOI: 10.1093/abbs/gmaa065.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Liu J., Wang Y., Ji P., Jin X. Application of the microRNA-302/367 cluster in cancer therapy. Cancer Sci 2020;111(4):1065–75. DOI: 10.1111/cas.14317.</mixed-citation><mixed-citation xml:lang="ru">Liu J., Wang Y., Ji P., Jin X. Application of the microRNA-302/367 cluster in cancer therapy. Cancer Sci 2020;111(4):1065–75. DOI: 10.1111/cas.14317.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Belge G., Hennig F., Dumlupinar C. et al. Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor. Oncotarget 2020;11(16):1462–73. DOI: 10.18632/oncotarget.27565.</mixed-citation><mixed-citation xml:lang="ru">Belge G., Hennig F., Dumlupinar C. et al. Graded expression of microRNA-371a-3p in tumor tissues, contralateral testes, and in serum of patients with testicular germ cell tumor. Oncotarget 2020;11(16):1462–73. DOI: 10.18632/oncotarget.27565.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Conduit C., Tran B. Improving outcomes in germ cell cancers using miRNA. Ther Adv Med Oncol 2021;13:175883592110278. DOI: org/10.1177/17588359211027826.</mixed-citation><mixed-citation xml:lang="ru">Conduit C., Tran B. Improving outcomes in germ cell cancers using miRNA. Ther Adv Med Oncol 2021;13:175883592110278. DOI: org/10.1177/17588359211027826.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Jenike A.E., Halushka M.K. MiR-21: a non-specific biomarker of all maladies. Biomark Res 2021;9(1):18. DOI: 10.1186/s40364-021-00272-1.</mixed-citation><mixed-citation xml:lang="ru">Jenike A.E., Halushka M.K. MiR-21: a non-specific biomarker of all maladies. Biomark Res 2021;9(1):18. DOI: 10.1186/s40364-021-00272-1.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Ludwig N., Leidinger P., Becker K. et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res 2016;44(8):3865–77. DOI: 10.1093/nar/gkw116.</mixed-citation><mixed-citation xml:lang="ru">Ludwig N., Leidinger P., Becker K. et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res 2016;44(8):3865–77. DOI: 10.1093/nar/gkw116.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25. Port M., Glaesener S., Ruf C. et al. Micro-RNA expression in cisplatin resistant germ cell tumor cell lines. Mol Cancer 2011;10:52. DOI: 10.1186/1476-4598-10-52.</mixed-citation><mixed-citation xml:lang="ru">Port M., Glaesener S., Ruf C. et al. Micro-RNA expression in cisplatin resistant germ cell tumor cell lines. Mol Cancer 2011;10:52. DOI: 10.1186/1476-4598-10-52.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26. Knyazeva M., Korobkina E., Karizky A. et al. Reciprocal dysregulation of miR-146b and miR-451 Contributes in malignant phenotype of follicular thyroid tumor. Int J Mol Sci 2020;21(17):5950. DOI: 10.3390/ijms21175950.</mixed-citation><mixed-citation xml:lang="ru">Knyazeva M., Korobkina E., Karizky A. et al. Reciprocal dysregulation of miR-146b and miR-451 Contributes in malignant phenotype of follicular thyroid tumor. Int J Mol Sci 2020;21(17):5950. DOI: 10.3390/ijms21175950.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27. Dieckmann K.-P., Radtke A., Geczi L. et al. Serum levels of microRNA-371a-3p (M371 Test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric study. J Clin Oncol 2019;37:1412–23. DOI: 10.1200/JCO.18.01480.</mixed-citation><mixed-citation xml:lang="ru">Dieckmann K.-P., Radtke A., Geczi L. et al. Serum levels of microRNA-371a-3p (M371 Test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric study. J Clin Oncol 2019;37:1412–23. DOI: 10.1200/JCO.18.01480.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28. Das A.V., Pillai R.M. Implications of miR cluster 143/145 as universal antioncomiRs and their dysregulation during tumorigenesis. Cancer Cell Int 2015;15:92. DOI: 10.1186/s12935-015-0247-4.</mixed-citation><mixed-citation xml:lang="ru">Das A.V., Pillai R.M. Implications of miR cluster 143/145 as universal antioncomiRs and their dysregulation during tumorigenesis. Cancer Cell Int 2015;15:92. DOI: 10.1186/s12935-015-0247-4.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. Zabegina L., Nazarova I., Knyazeva M. et al. MiRNA let-7 from TPO(+) extracellular vesicles is a potential marker for a differential diagnosis of follicular thyroid nodules. Cells 2020;9(8):1917. DOI: 10.3390/cells9081917.</mixed-citation><mixed-citation xml:lang="ru">Zabegina L., Nazarova I., Knyazeva M. et al. MiRNA let-7 from TPO(+) extracellular vesicles is a potential marker for a differential diagnosis of follicular thyroid nodules. Cells 2020;9(8):1917. DOI: 10.3390/cells9081917.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
